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Background. Studies conducted in Europe and the USA have shown that co-morbidity between major depressive
disorder (MDD) and anxiety disorders is associated with various MDD-related features, including clinical symptoms,
degree of familial aggregation and socio-economic status. However, few studies have investigated whether these
patterns of association vary across diﬀerent co-morbid anxiety disorders. Here, using a large cohort of Chinese
women with recurrent MDD, we examine the prevalence and associated clinical features of co-morbid anxiety
disorders.
Method. A total of 1970 female Chinese MDD patients with or without seven co-morbid anxiety disorders [including
generalized anxiety disorder (GAD), panic disorder, and ﬁve phobia subtypes] were ascertained in the CONVERGE
study. Generalized linear models were used to model association between co-morbid anxiety disorders and various
MDD features.
Results. The lifetime prevalence rate for any type of co-morbid anxiety disorder is 60.2%. Panic and social phobia
signiﬁcantly predict an increased family history of MDD. GAD and animal phobia predict an earlier onset of MDD
and a higher number of MDD episodes, respectively. Panic and GAD predict a higher number of DSM-IV diagnostic
criteria. GAD and blood-injury phobia are both signiﬁcantly associated with suicidal attempt with opposite eﬀects.
All seven co-morbid anxiety disorders predict higher neuroticism.
Conclusions. Patterns of co-morbidity between MDD and anxiety are consistent with ﬁndings from the US and
European studies; the seven co-morbid anxiety disorders are heterogeneous when tested for association with various
MDD features.
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ORIGINAL ARTICLEIntroduction
A large number of studies agree that anxiety disorders
occur in patients with major depressive disorder
(MDD) far more frequently than expected by chance
(Kessler et al. 1996; Gorwood, 2004). In fact, in clinical
settings, more than half of MDD patients have co-
morbid anxiety disorders (Zimmerman & Chelminski,
2003). Furthermore, a number of clinical features
characterize MDD patients with co-morbid anxiety.
Typically, their depressive disorder is more severe,
with more episodes, earlier onset age, greater suicidal
risk and poorer treatment response (Brown et al. 2001);
they have a lower social competence (Cerda ´ et al.
2010); and they are more likely to have a family his-
tory of MDD (Clayton et al. 1991; Kendler et al. 1992).
A number of explanations have been put forward to
explain this co-morbidity. In part, it appears to arise
from a shared genetic propensity to both anxiety and
depression: multivariate twin modeling has identiﬁed
a common genetic factor contributing to internalizing
disorders, including MDD, generalized anxiety dis-
order (GAD) and phobias (Kendler et al. 2003).
However, a common genetic origin is clearly not
the whole explanation. Genetic studies themselves
indicate that there are some genetic factors that act
speciﬁcally on anxiety and MDD (Kendler et al. 2003).
They also show that the genetic factors explain only
part of the co-occurrence of illnesses. We know that
non-shared environment explains almost all the co-
variance between MDD and agoraphobia and more
than 40% between MDD and GAD for female twins
(Cerda ´ et al. 2010). Our understanding of the non-
genetic factors that drive co-morbidity is still very
limited. The responsible environmental factors remain
to be identiﬁed but it has been shown that low socio-
economic status in childhood and adult unemploy-
ment distinguishes the MDD GAD co-morbid group
from the MDD-only group (Cerda ´ et al. 2010).
Studies that investigate the prevalence and features
of MDD associated with co-morbid anxiety typically
examine the relationship between MDD and a single
anxiety disorder (such as GAD or panic disorder)
(Garvey et al. 1987; Reich et al. 1993; Grunhaus et al.
1994; Maier et al. 1995; Kessler et al. 1998, 1999;
Gorwood, 2004; Kendler et al. 2007). A few studies
(Pini et al. 1997; Fava et al. 2000; Lamers et al. 2011)
report that there are diﬀerences in the prevalence rates
of co-morbid anxiety disorders, but rarely distinguish
or control for diﬀerent co-morbid anxiety disorders
when testing for association with MDD-related fea-
tures (Kessler et al. 2003; Fava et al. 2004; Rhebergen
et al. 2011). This leaves open an important question: is
there similarity in the clinical features of patients with
MDD with diﬀerent co-morbid anxiety disorders?
One possibility is that co-morbidity arises from
separate and independent associations with each
anxiety disorder, as reﬂected in the pattern of associ-
ations with symptoms, severity indices and risk
factors. The alternative is that co-morbidity reﬂects a
common mechanism among all anxiety disorders.
In this article, we examine co-morbid anxiety in a
large cohort of female Han Chinese recruited through
clinical settings and diagnosed with recurrent MDD
using a structured clinical interview. We set out to
determine ﬁrst whether co-morbidity between anxiety
and depression was similar in China to that observed
elsewhere in the world. Our information about co-
morbid anxiety disorders, and the attendant clinical
pattern, is currently derived almost exclusively from
studies of European and US populations. To our
knowledge, no one has examined whether the
same pattern of co-morbidity holds true for MDD in
China. Second, we asked how similar were the clinical
features of MDD patients with diﬀerent anxiety dis-
orders, by comparing diﬀerences in association
between clinical features of MDD and diﬀerent co-
morbid anxiety disorders. Distinguishing the clinical
features of diﬀerent types of anxiety disorders helps
us to identify risk factors that are associated with
each anxiety disorder speciﬁcally, which may in turn
alter the ways patients with MDD who have co-
morbid anxiety disorders are assessed and the treat-
ments they are oﬀered.
Study subjects
Data for the present study were drawn from the on-
going China, Oxford and VCU Experimental Research
on Genetic Epidemiology (CONVERGE) study of
MDD. The analysis was based on a total of 1970 cases
recruited from 51 mental health centers and psychi-
atric departments of general medical hospitals in
40 cities in 21 provinces.
The project utilized samples collected for a genome-
wide association study of MDD. Given evidence that
the genetic eﬀects on MDD are diﬀerent between men
and women (Kendler et al. 2001), in order to control
for this known genetic heterogeneity, we collected
female participants only with four Han Chinese
grandparents. Cases were excluded if they had a pre-
existing history of bipolar disorder, any type of psy-
chosis or mental retardation. Cases were aged between
30 and 60 years, had two or more episodes of MDD
with the ﬁrst episode occurring between the ages of
14 and 50 years, and had not abused drugs or alcohol
before their ﬁrst episode.
All subjects were interviewed using a computerized
assessment system, which lasted on average 2 h.
All interviewers, who were postgraduate medical
1240 Y. Li et al.students, junior psychiatrists or senior nurses, were
trained by the CONVERGE team for a minimum of
1 week. The interview includes assessment of psy-
chopathology, demographic and personal charac-
teristics, and psychosocial functioning. Interviews were
tape-recorded and a proportion of them were listened
to by the trained editors, who provided feedback
on their quality. The study protocol was approved
centrally by the Ethical Review Board of Oxford
University and the ethics committee in participating
hospitals in China.
Measures
The diagnoses of depressive (dysthymia and MDD)
and anxiety disorders (GAD, panic disorder with
or without agoraphobia) were established with the
Composite International Diagnostic Interview (World
Health Organization lifetime version 2.1; Chinese
version), which classiﬁes diagnoses according to the
Diagnostic and Statistical Manual of Mental Disorders,
fourth edition (DSM-IV) criteria. The interview was
originally translated into Mandarin by a team of psy-
chiatrists in Shanghai Mental Health Center, with the
translation reviewed and modiﬁed by members of the
CONVERGE team. Phobias, divided into ﬁve subtypes
(animal, situational, social and blood-injury, and
agoraphobia), were diagnosed using an adaptation
of DSM-IV criterion D (APA, 1994) requiring one or
more unreasonable fears, including fears of diﬀerent
animals, social phobia and agoraphobia, that objec-
tively interfered with the respondents’ life or resulted
in severe anxiety when exposed to the phobic stimu-
lus. The section on the assessment of phobias was
translated by the CONVERGE team from the inter-
view used in the Virginia Adult Twin Study of
Psychiatric and Substance Use Disorders (VATSPUD)
(Kendler & Prescott, 2006). The history of lifetime
major depression in the parents and siblings was
assessed using the Family History Research Diagnos-
tic criteria (Endicott et al. 1975). Neuroticism was
measured with the 23-item Eysenck Personality
Questionnaire (Eysenck & Eysenck, 1975).
All interview sections were fully computerized into
a bilingual system of Mandarin and English devel-
oped in-house in Oxford, UK, called SysQ (a self-
administered interview system). Skip patterns were
built into SysQ. Interviews were administered by
trained interviewers and entered oﬄine in real time
onto SysQ, which was installed in laptop computers.
Once an interview was completed, a backup ﬁle
containing all the previously entered interview data
could be generated with a database-compatible
format. The backup ﬁle together with an audio record
of the entire interview was uploaded to a designated
server currently maintained in Beijing by a service
provider. All the uploaded ﬁles in the Beijing server
were then transferred to an Oxford server quarterly.
The diagnoses of MDD were based on information
collected in the medical records and DSM-IV symp-
toms during the worst episode. Symptoms infor-
mation collected for the diagnoses of co-morbid
disorders of MDD was for lifetime.
Statistical methods: generalized linear regression
model choosing, analysis of variance (ANOVA)
In order to test whether co-morbid anxiety disorders
signiﬁcantly predict various MDD features, including
family history, age of onset, number of episodes,
number of DSM-IV diagnostic criteria, suicidal at-
tempt and neuroticism score, generalized linear
models (GLMs) with diﬀerent link functions were
chosen for modeling diﬀerent types of dependent
variables controlling for age. Data for the age of onset
were tested for normality and modeled with linear
regression, and results represented as the standar-
dized parameter estimate (b). Suicidal attempt was
modeled with logistic regression and results re-
presented as odds ratios (ORs). The family history
variable, represented by the total number of ﬁrst-
degree family members among the two parents and
all the siblings with a history of MDD, could be con-
sidered as a series of Bernoulli trials with a ﬁnite
number of trials in statistical terms; hence binomial
regression was used for modeling the association,
weighted against the total number of family members
for each subject. The same reason and choice were
applied to variables such as the number of DSM-IV
diagnostic criteria and the neuroticism score, which
could also be considered as a ﬁnite number of
Bernoulli trials. Poisson regression was chosen to
model the number of episodes data, as it is considered
to be count data with an upper limit of 96 (denoting 96
or more) being removed. Since binomial and Poisson
regressions model the natural logarithms of the
count and the event rate, respectively, results are re-
presented by count ratio (CR) and rate ratio (RR), both
calculated by exponentiating the regression coeﬀ-
icients. The statistical tests were implemented using R
(R Development Core Team, 2011), which allows the
speciﬁcation of quasibinomial and quasipoisson link
functions. They diﬀer from binomial and Poisson
functions only in that the dispersion parameter is not
ﬁxed at 1; in other words, over-dispersion is included
in the model, which controls for the over-reporting of
false-positive results.
In addition to calculating the individual eﬀects of
the seven co-morbid anxieties, the method of Analysis
of Deviance for GLM Fits (ANOVA) was used to
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the multiple GLMs were homogeneous or hetero-
geneous in predicting each of the MDD features. Two
GLM objects were speciﬁed in ANOVA; one with a
derived independent variable which is calculated as
the sum of all seven anxiety diagnostic status, nested
by another containing all the seven co-morbid anxiety
diagnoses as additive independent variables. The
result gives a table with a row for the residual degrees
of freedom and deviance for each model. Test statistics
could be speciﬁed in ANOVA, comparing the re-
duction in deviance for the row to the residuals. For
models with dispersion estimated by moments, such
as Gaussian, quasibinomial and quasipoisson ﬁts, the
F test is considered to be the most appropriate.
Results
The lifetime prevalence rate in our sample of women
with recurrent MDD for any of the seven co-morbid
anxiety disorders was 60.2%. The rates of the indi-
vidual anxiety disorders in our cohort were 26.4% for
GAD, 10.1% for panic disorder, 15.0% for agora-
phobia, 14.3% for social phobia, 28.0% for animal
phobia, 20.3% for situational phobia, and 21.7% for
blood-injury phobia.
The mean number of co-morbid anxiety disorders
among the MDD patients was 1.35 (S.D.=1.56). Among
the 1136 MDD (59.8%) patients who had at least one of
the seven co-morbid anxiety disorders, 59.3% patients
had two or more co-morbid anxiety disorders. Of the
seven anxiety disorders, there are 128 possible combi-
nations of what a patient might or might not have.
Table 1 contains the top 13 combinations including the
40.2% of MDD patients without any of the seven co-
morbid anxiety disorders, 16.2% with GAD only, 8.8%
with animal phobia only, and 5.1% with blood-injury
phobia only, etc. The top 12 combinations (excluding
the non-anxious group) accounted for 54.1% of all the
MDD cases with co-morbid anxiety disorders. Because
so many patients had more than one condition, we
used a multiple regression model in order to tease
apart individual eﬀects.
We looked at the relationship between clinical
features of MDD and the seven anxiety disorders,
attempting to identify those that were shared between
disorders or were disorder-speciﬁc. Tables 2 and 3
contain the summary statistics of the variables in-
cluded in the regression analysis. We ﬁrst tested the
eﬀect of each disorder separately. Then we combined
all disorders into one model to test for their joint eﬀect
on each MDD feature.
We found signiﬁcant eﬀects for each disorder when
tested separately, as well as combining the seven
diagnoses into one variable – any type of anxiety dis-
order (Table 4). Results for jointly testing disorders are
more complex and are shown in Table 5. Panic and
social phobia independently signiﬁcantly predicted an
increased family history of MDD, with social phobia
showing the highest eﬀect (CR 1.52, p=5.58r10x4),
controlling for the additive eﬀects of the other co-
morbid anxiety disorders. GAD with one or more
Table 2. Variables included in general linear models
Mean (S.D.) NA
Age, years 45.11 (8.84) 16
Age of onset, years 35.87 (9.97) 45
Number of episodes
(excluding 96 or morea)
4.20 (5.03) 44
Number of DSM-IV diagnostic criteria 8.28 (1.05) 39
Number of positively diagnosed
family members
0.49 (0.83) 53
Number of family members 4.95 (1.75) 53
Neuroticism 12.72 (5.84) 55
S.D., Standard deviation; NA, number of missing data
entries; DSM, Diagnostic and Statistical Manual of Mental
Disorders.
aSee Statistical methods section.
Table 1. Top 13 combinations among the total of 128 possibilities
with seven co-morbid anxiety disorders that could either be
present or not present in every patient with major depressive
disorder
128 possibilities Number (%)
Top 13 combinations
No anxiety 765
GAD only 184 (16.20)
Animal phobia only 100 (8.80)
Blood-injury phobia only 58 (5.11)
Situational phobia only 45 (3.96)
GAD and animal phobia 40 (3.52)
Animal and blood-injury phobia 33 (2.90)
Animal and situational phobia 29 (2.55)
Panic only 29 (2.55)
Animal and situational and
blood-injury phobia
27 (2.38)
Social phobia only 26 (2.29)
GAD and blood-injury phobia 24 (2.11)
Agoraphobia only 20 (1.76)
Total of top 12 combinations
(excluding the non-anxious group)
615 (54.14)
Total of other combinations
(excluding the non-anxious group)
521 (45.86)
Total (excluding the non-anxious group) 1136 (100.00)
GAD, Generalized anxiety disorder.
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signiﬁcantly predicted earlier MDD onset age. Animal
phobia (RR 1.18, p=1.12r10x2) signiﬁcantly predicted
higher number of MDD episodes. Panic and GAD
independently signiﬁcantly predicted higher numbers
of positive DSM-IV diagnostic criteria, with GAD
(CR 1.70, p=3.62r10x8) showing the largest and most
signiﬁcant eﬀect. GAD and blood-injury phobia were
signiﬁcantly associated with the probability of a sui-
cide attempt, with GAD predicting higher probability
(OR 1.38, p=9.95r10x3), and blood-injury phobia
predicting lower probability (OR 0.66, p=9.35r10x3).
All anxiety disorders independently and signiﬁcantly
predicted a higher neuroticism score, with GAD
(CR 1.69, p=7.42r10x22) showing the highest eﬀect.
We looked for common patterns in the way that
anxiety disorders made an impact on the clinical
features of MDD. Our hypothesis was that we would
ﬁnd some clinical features on which one or more
anxiety disorder had similar impacts, as assessed
Table 3. Suicide-related response rates and major depressive disorder prevalence rates for
both parents
Items
Positive
diagnoses
Negative
diagnoses Total (%) NA
Suicide features
Suicidal thought 1196 739 1935 (61.81) 35
Suicidal plan 830 1105 1935 (42.89) 35
Suicidal attempt 423 1512 1935 (21.86) 35
Family history
Father 192 1486 1678 (11.44) 292
Mother 301 1427 1728 (17.42) 242
NA, Number of missing data entries.
Table 4. Eﬀects of generalized linear models testing for association between each co-morbid
anxiety disorder as well as any of the seven co-morbid anxiety disorders, and major
depressive disorder features taken one at a timea
Anxiety
disorder FHb AAOc NEd NDCb SAe Nb
Panic 1.53*** 0.01# 1.16## 1.83*** 0.80* 1.63***
GAD 1.26* x0.04* 1.08# 1.85*** 1.53*** 1.84***
Agoraphobia 1.63*** x0.01# 1.13## 1.58*** 1.38*** 1.71***
Social phobia 1.88*** x0.02# 1.18* 1.51*** 1.35*** 1.78***
Animal phobia 1.40*** x0.02# 1.22*** 1.35*** 1.24*** 1.56***
Situational phobia 1.46*** 0.00# 1.11# 1.33*** 1.27** 1.62***
Blood-injury phobia 1.50*** 0.01# 1.12## 1.46*** 0.84** 1.56***
Any 1.56*** x0.04* 1.20** 1.73*** 1.33*** 1.80***
FH, Family history; AAO, age of onset; NE, number of episodes; NDC, number of
Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria; SA, suicidal
attempt; N, neuroticism; GAD, generalized anxiety disorder; OR, odds ratio; CR,
count ratio; RR, rate ratio.
aValues reported for the four types of regression models: linear regression: stan-
dardized parameter estimates (b); logistic regression: OR; quasi-binomial re-
gression: CR; quasi-Poisson regression: RR. ORs, CRs and RRs were calculated by
exponentiating the regression coeﬃcients.
bQuasibinomial regression was used to model FH, NDC and N.
cLinear regression was used to model AAO.
dQuasipoisson regression was used to model NE.
eLogistic regression was used to model SA.
*p<0.05, ** p<0.01, *** p<0.001.
#p<1, ## p<0.1.
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We applied a global heterogeneity test for the multiple
regression coeﬃcients. The results showed that coeﬃ-
cients of the seven co-morbid anxiety disorders were
homogeneous with respect to their association with
family history, age of onset and the number of episode
data. However, they were heterogeneous with respect
to their association with the number of DSM-IV diag-
nostic criteria (F=3.48, p=1.99r10x3), suicidal at-
tempt (F=2.79, p=1.02r10x2) and neuroticism score
(F=5.72, p=6.64r10x6) (Table 6). When the diag-
noses of all seven co-morbid anxiety disorders were
included in a multiple regression model, controlling
for each other’s additive eﬀects, the ones that were
signiﬁcant when tested for association with various
MDD features were diﬀerent, such that only GAD
predicted earlier MDD onset, whereas only animal
phobia predicted more episodes of MDD. Results from
global heterogeneity tests also indicated that MDD
patients with diﬀerent co-morbid anxiety disorders
manifested diﬀerent clinical features.
Discussion
Our work establishes two important ﬁndings: ﬁrst, in
China co-morbidity between MDD and anxiety dis-
orders is similar to that reported in the West; second,
there is important heterogeneity in the association
between anxiety disorders and some clinical features
of MDD. We discuss these two points below.
The lifetime prevalence rate for any type of co-
morbid anxiety disorder among MDD patients re-
cruited through clinical settings is 60.2%. This is
higher than the 50.6% lifetime rate reported in the
Depression Research Program with patients recruited
through clinical settings (Fava et al. 2000), and lower
Table 6. ANOVA F test examining the heterogeneity of the multiple regression coeﬃcients of the seven co-morbid anxiety disorders in
predicting each of the six major depressive disorder features
Anxiety FH AAO NE NDC SA N
ANOVA F test 1.04 1.32 0.59 3.48 2.79 5.72
ANOVA p value 0.40 0.25 0.74 1.99r10x3 1.02r10x2 6.64r10x6
ANOVA, Analysis of variance; FH, family history; AAO, age of onset; NE, number of episodes; NDC, number of Diagnostic
and Statistical Manual of Mental Disorders (DSM)-IV criteria; SA, suicidal attempt; N, neuroticism.
Table 5. Eﬀects of multivariate generalized linear models testing for association between the seven co-morbid anxiety disorders all
considered together and various major depressive disorder featuresa
Anxiety disorder FHb AAOc NEd NDCb SAe Nb
Panic 1.32* 0.01# 1.10# 1.58** 0.78# 1.31**
GAD 1.11# x0.04* 1.04# 1.70*** 1.38** 1.69***
Agoraphobia 1.16# x0.01# 1.01# 1.18# 1.25# 1.17*
Social phobia 1.52*** x0.02# 1.09# 1.15# 1.18# 1.29***
Animal phobia 1.10# x0.02# 1.18* 1.08# 1.12# 1.18**
Situational phobia 1.06# 0.00# 0.99# 1.03# 1.24# 1.20**
Blood-injury phobia 1.21## 0.03# 1.03# 1.22## 0.66** 1.19**
Over-dispersion parameterf 1.51# – 5.58# 1.61# – 5.32#
FH, Family history; AAO, age of onset; NE, number of episodes; NDC, number of Diagnostic and Statistical Manual of
Mental Disorders (DSM)-IV criteria; SA, suicidal attempt; N, neuroticism; GAD, generalized anxiety disorder; OR, odds ratio;
CR, count ratio; RR, rate ratio.
aValues reported for the four types of regression models: linear regression: standardized parameter estimates (b);
logistic regression: OR; quasi-binomial regression: CR; quasi-Poisson regression: RR. ORs, CRs and RRs were calculated
by exponentiating the regression coeﬃcients.
bQuasibinomial regression was used to model FH, NDC and N.
cLinear regression was used to model AAO.
dQuasipoisson regression was used to model NE.
eLogistic regression was used to model SA.
fThe over-dispersion parameter was included in the model due to the quasi-terms.
*p<0.05, ** p<0.01, *** p<0.001.
#p<1, ## p<0.1.
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Study of Depression and Anxiety (NESDA) with
patients mostly recruited through primary care (54%)
and specialized mental health settings (27%) (Lamers
et al. 2011). Additionally, the reported lifetime
co-morbidity rates for panic disorder among MDD
patients in a cross-national epidemiological survey
study are 10.7% in the USA, 16.2% in West Germany,
17% in Korea and 5.9% in Taiwan (Weissman et al.
1996). The ﬁgure in Taiwan is lower than the 10.1%
reported in our study. Diﬀerent sampling frames and
disorder diagnostic criteria should be taken into con-
sideration when comparing these ﬁgures; for example,
our study recruited patients with recurrent MDD
through clinical settings while the cross-national
epidemiological survey studied community samples.
Despite the sampling diﬀerences, we found that the
clinical features of co-morbidity are generally consist-
ent in China with those reported elsewhere in the
world: co-morbidity is associated with increased
MDD severity and chronic course, suicidal attempts,
higher rates of neuroticism, and increased familial
aggregation (Coryell et al. 1992; Kessler et al. 1998,
2003; Fava et al. 2000, 2004; Sareen et al. 2005; Bolton
et al. 2008; Hettema, 2008; Howland et al. 2009; Lamers
et al. 2011). The similarity we observed between co-
morbidity in China and the rest of the world en-
courages us to believe that our other ﬁndings will be
applicable elsewhere. The diagnoses of MDD and co-
morbid anxiety disorders in our sample are lifetime.
In a large clinical study, the current co-morbidity rate
of any anxiety disorder was found to be 64% among
current MDD patients, whereas the co-morbidity rate
of lifetime diagnoses was 95% (Brown et al. 2001).
Hence we expect a large proportion of our patients
with lifetime co-morbidity also would have had con-
current co-morbidity. However, this cannot be proved
with our data.
Our second important ﬁnding concerns the hetero-
geneity of co-morbid anxiety disorders. Our large data
set allowed us to ask whether co-morbidity between
MDD and one anxiety disorder is the same as co-
morbidity between MDD and other anxiety disorders:
for example, whether patients with co-morbid GAD
look more or less similar in their clinical presentation
and known risk factors for MDD to patients with co-
morbid social phobia. Our results indicate that there is
considerable heterogeneity, and that when we talk of
co-morbid anxiety it would be best to mean by this
distinct co-morbidities with speciﬁc anxiety disorders
rather than generic co-morbidity across all the anxiety
disorders.
Signiﬁcant heterogeneity was observed for three of
the six MDD features that were tested for association
with co-morbid anxiety disorders. They are (i) the
number of MDD diagnostic criteria, (ii) suicidal at-
tempt and, (iii) neuroticism measure. When control-
ling for the eﬀects of all seven co-morbid anxiety
disorders, we found that GAD predicts earlier onset
and a higher number of DSM-IV criteria; panic dis-
order predicts higher number of DSM-IV criteria;
animal phobia predicts higher number of episodes.
There are conﬂicting results about whether co-morbid
anxiety disorders are risk factors for suicide attempt
among MDD patients (Roy, 1993; Sareen et al. 2005;
Claassen et al. 2007; Bolton et al. 2008; Brown et al.
2010; Perroud et al. 2010). Our ﬁndings suggest
that some co-morbid anxiety disorders (i.e. GAD)
increase the risk for suicidal attempt, whereas others
(i.e. blood-injury phobia) may be protective perhaps
because the disorder is associated with a fear of death.
Hence, treating all types of anxiety disorder together
when testing for association with suicidal attempt
might counterbalance the opposite eﬀects, resulting in
insigniﬁcant ﬁndings. Studies examining the relation-
ship between co-morbid panic disorder and suicidal
attempt show that either panic disorder increases the
risk for suicidal attempt (Claassen et al. 2007) or the
association is insigniﬁcant (Placidi et al. 2000). Our
results disagree with most previous ﬁndings in sug-
gesting that co-morbid panic disorder is protective
against suicidal attempt. However, if we apply a
conservative correction for multiple testing then this
observation becomes non-signiﬁcant, so only further
study of this question will determine if this ﬁnding
in Chinese women represents a true or false-positive
result. Neuroticism showed the clearest pattern of
heterogeneity: the test of heterogeneity gave the most
signiﬁcant of all results (p=6.64r10x6).
We hypothesize that examining anxiety disorders as
a single class hides important heterogeneity in their
association with MDD. Heterogeneity is likely to be
due to two factors: (i) opposite eﬀects among diﬀerent
anxiety disorders; and (ii) individual eﬀects of diﬀer-
ent anxiety disorders. Evidence for the former comes
from results on suicidal attempt. While we found that
all seven co-morbid anxiety disorders were signiﬁ-
cantly associated with suicidal attempt when tested
separately, the direction of the eﬀect diﬀers: some
anxiety disorders increase the occurrence of suicide
attempts (GAD), while others (panic and blood-injury
phobia) are protective (even when controlling for all
the other co-morbid anxiety disorders).
Evidence for the latter comes from results on the
number of DSM-IV diagnostic criteria and neuro-
ticism. One important source for heterogeneity lies
in diﬀering genetic susceptibilities to each co-morbid
condition. Thus, while we know that there is a
common genetic predisposition to MDD and anxiety
(Bienvenu et al. 2001; Khan et al. 2005; Middeldorp
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Rhebergen et al. 2011), we also know that there are
some unique genetic eﬀects on anxiety disorders.
For example, some genetic eﬀects are shared between
neuroticism and anxiety disorders; others are unique.
The pattern of what is shared and what is common is
speciﬁc to each condition.
The ﬁndings from the study have implications for
the recognition, diagnosis and possibly treatment of
MDD patients with diﬀerent co-morbid anxiety dis-
orders. For instance, the presence of GAD should alert
doctors that the MDD patient is likely to be of a more
severe kind, indicated by earlier onset and more
symptom criteria, with suicidal ideation. Hence inter-
vention could be applied at an earlier stage to prevent
more negative outcomes.
Limitations
The reported results should be interpreted in the
context of ﬁve potential limitations.
First, we only studied female patients and the
relevance of our results to male patients is unknown.
Second, the criteria used for the diagnoses of co-
morbid disorders of MDD were lifetime; hence the
diagnoses of the seven anxiety disorders might not
be co-morbid as in they might not have occurred
concurrently with the worst episode of MDD. Third,
patients were recruited through clinical settings;
hence representativeness of our ﬁndings to the general
population in China and the rest of the world is un-
known. Fourth, cases recruited in the study were
patients with at least two episodes of MDD; hence
when co-morbid anxieties were tested for association
with the number of episodes data, the eﬀects and sig-
niﬁcance of eﬀects were likely to be reduced compared
with samples that only fulﬁlled the clinical diagnoses
of MDD without the additional recruitment criteria.
This might also have implications for the results of
the global heterogeneity test for multiple regression
coeﬃcients. Fifth, our study diﬀers from traditional
family studies of anxiety disorders which involve the
personal interview of ﬁrst-degree family members
(Crowe et al. 1983; Fyer et al. 1990; Brown et al. 1993;
Weissman et al. 1993). Given the size of our study, it
was only feasible to collect family history information
from the patient about ﬁrst-degree family members.
An extensive literature on the family history method
indicates that, in general, it has low sensitivity but
high speciﬁcity (Andreasen et al. 1977, 1986; Roy et al.
1996), although some evidence for bias has been
detected (Kendler et al. 1991). Furthermore, due to the
design of our study, we do not have patients with
anxiety but without MDD; hence we cannot fully test
the transmission of MDD and the anxiety disorders.
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